Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6726492, 7 pages
http://dx.doi.org/10.1155/2016/6726492
Research Article

Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients

1Department of Pathophysiology, Medical Faculty, Masaryk University Brno, Kamenice 5, 62500 Brno, Czech Republic
2Institute of Biostatistics and Analyses, Masaryk University Brno, Kamenice 126/3, 62500 Brno, Czech Republic
3Department of Internal Medicine-Gastroenterology, University Hospital Brno, Jihlavská 20, 62500 Brno, Czech Republic
42nd Department of Internal Medicine, St. Anne’s University Hospital, Pekařská 53, 65691 Brno, Czech Republic

Received 24 July 2015; Revised 13 November 2015; Accepted 24 November 2015

Academic Editor: Dirk Westermann

Copyright © 2016 Vendula Bartáková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Palatini and S. Julius, “Elevated heart rate: a major risk factor for cardiovascular disease,” Clinical and Experimental Hypertension, vol. 26, no. 7-8, pp. 637–644, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Fox, J. S. Borer, A. J. Camm et al., “Resting heart rate in cardiovascular disease,” Journal of the American College of Cardiology, vol. 50, no. 9, pp. 823–830, 2007. View at Publisher · View at Google Scholar
  3. M. Woodward, R. Webster, Y. Murakami et al., “The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts,” European Journal of Preventive Cardiology, vol. 21, no. 6, pp. 719–726, 2014. View at Publisher · View at Google Scholar
  4. C. C. Lang, S. Gupta, P. Kalra et al., “Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms,” Atherosclerosis, vol. 212, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Stettler, A. Bearth, S. Allemann et al., “QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up,” Diabetologia, vol. 50, no. 1, pp. 186–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Linnemann and H. U. Janka, “Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen diabetes study,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 4, pp. 215–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Hillis, M. Woodward, A. Rodgers et al., “Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus,” Diabetologia, vol. 55, no. 5, pp. 1283–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. S. Hillis, J. Hata, M. Woodward et al., “Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus,” Journal of the American Heart Association, vol. 1, no. 5, Article ID e002832, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Miot, S. Ragot, W. Hammi et al., “Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort,” Diabetes Care, vol. 35, no. 10, pp. 2069–2075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Krolewski, M. A. Niewczas, J. Skupien et al., “Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria,” Diabetes Care, vol. 37, no. 1, pp. 226–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Krolewski, T. Gohda, and M. A. Niewczas, “Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes,” Clinical and Experimental Nephrology, vol. 18, no. 4, pp. 571–583, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Pugliese, A. Solini, E. Bonora et al., “Chronic kidney disease in type 2 diabetes: lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 24, no. 8, pp. 815–822, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. D. Lindeman, J. Tobin, and N. W. Shock, “Longitudinal studies on the rate of decline in renal function with age,” Journal of the American Geriatrics Society, vol. 33, no. 4, pp. 278–285, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Gray, “A class of K-sample tests for comparing the cumulative incidence of a competing risk,” The Annals of Statistics, vol. 16, no. 3, pp. 1141–1154, 1988. View at Publisher · View at Google Scholar · View at MathSciNet
  15. J. P. Fine and R. J. Gray, “A proportional hazards model for the subdistribution of a competing risk,” Journal of the American Statistical Association, vol. 94, no. 446, pp. 496–509, 1999. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet · View at Scopus
  16. A. S. Krolewski, “Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes,” Diabetes Care, vol. 38, no. 6, pp. 954–962, 2015. View at Publisher · View at Google Scholar
  17. J.-F. Morcet, M. Safar, F. Thomas, L. Guize, and A. Benetos, “Associations between heart rate and other risk factors in a large French population,” Journal of Hypertension, vol. 17, no. 12, pp. 1671–1676, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. ADVANCE Management Committee, “Study rationale and design of ADVANCE: action in diabetes and vascular disease—preterax and diamicron MR controlled evaluation,” Diabetologia, vol. 44, no. 9, pp. 1118–1120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Böhm, J. C. Reil, N. Danchin, M. Thoenes, P. Bramlage, and M. Volpe, “Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH,” Journal of Hypertension, vol. 26, no. 1, pp. 18–25, 2008. View at Publisher · View at Google Scholar
  20. T. Nakagawa, K. Tanabe, B. P. Croker et al., “Endothelial dysfunction as a potential contributor in diabetic nephropathy,” Nature Reviews Nephrology, vol. 7, no. 1, pp. 36–44, 2011. View at Publisher · View at Google Scholar
  21. P. Palatini, “Elevated heart rate in cardiovascular diseases: a target for treatment?” Progress in Cardiovascular Diseases, vol. 52, no. 1, pp. 46–60, 2009. View at Publisher · View at Google Scholar
  22. American Diabetes Association, “Standards of medical care in diabetes—2008,” Diabetes Care, vol. 31, supplement 1, pp. S12–S54, 2008. View at Publisher · View at Google Scholar
  23. A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003. View at Publisher · View at Google Scholar · View at Scopus